MedTrace Logo

A Study to Evaluate the Effectiveness of Essure Post-NovaSure Radiofrequency Endometrial Ablation Procedure Following a Successful Essure Confirmation Test

NCT01740687 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 211

Last updated 2023-02-06

Study results available
· View outcomes & findings →

Summary

The purpose of the post approval study is to evaluate the effectiveness and safety of the Essure System when a NovaSure Endometrial Ablation procedure is performed following a successful Essure Confirmation Test.

Conditions

  • Contraception
  • Menorrhagia

Interventions

DEVICE

ESS305 (Essure, BAY1454032)

Essure Permanent Birth Control

PROCEDURE

NovaSure

Nova Sure Endometrial Ablation

Sponsors & Collaborators

Principal Investigators

  • Bayer Study Director · Bayer

Eligibility

Min Age
21 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-11-13
Primary Completion
2021-05-17
Completion
2021-06-14

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01740687 on ClinicalTrials.gov